2-tyrosine has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brasnyó, P; Cseh, J; Halmai, R; Laczy, B; Markó, L; Mérei, A; Mészáros, LG; Mikolás, E; Mohás, M; Molnár, GA; Sümegi, B; Szijártó, IA; Wittmann, I | 1 |
| Biró, Z; Ludány, A; Molnár, GA; Nemes, V; Wagner, Z; Wittmann, I | 1 |
1 trial(s) available for 2-tyrosine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.
Topics: Adult; Blood Platelets; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Insulin Resistance; Male; Middle Aged; Oxidative Stress; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Tyrosine | 2011 |
1 other study(ies) available for 2-tyrosine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Accumulation of the hydroxyl free radical markers meta-, ortho-tyrosine and DOPA in cataractous lenses is accompanied by a lower protein and phenylalanine content of the water-soluble phase.
Topics: Aged; Cataract; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Dihydroxyphenylalanine; Eye Proteins; Humans; Hydroxyl Radical; Lens, Crystalline; Middle Aged; Phenylalanine; Solubility; Tyrosine; Water | 2005 |